{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-088448","form_type":"8-K","ticker":"ALGS","cik":"0001799448","company_name":"Aligos Therapeutics, Inc.","filed_at":"2022-03-30T23:59:59+00:00","discovered_at":"2026-05-14T18:04:08.268539+00:00","generated_at":"2026-06-26T13:50:30.742757+00:00","sec_items":["8.01"],"event_type":"litigation","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Aligos Therapeutics sued by Janssen over breach of contract, IP ownership","bullets":["Janssen Biopharma filed complaint in Superior Court of California, San Mateo County on March 26, 2022.","Alleges breach of contract by CEO Lawrence Blatt and President Leonid Beigelman, tortious interference by Aligos.","Janssen seeks declaratory judgment on IP ownership, injunctive relief, and monetary damages.","Company believes allegations are without merit and intends to defend vigorously."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-088448","json":"https://secwatch.observer/filing/0001193125-22-088448.json","markdown":"https://secwatch.observer/filing/0001193125-22-088448.md","text":"https://secwatch.observer/filing/0001193125-22-088448.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799448/000119312522088448/0001193125-22-088448-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799448/000119312522088448/d284014d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T13:50:30.742757+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}